This report details the investment in General Practice and the reimbursement for drugs dispensed in General Practices from 2013/14 to 2017/18.
The report draws on information obtained from the financial reporting systems of the health departments of each country, and other published data on reimbursement and remuneration for dispensing activity. These are discussed and subsequently agreed by the Technical Steering Committee (TSC), which is chaired by NHS Digital and has representation from the Department of Health and Social Care, UK Health Departments, NHS England, NHS Employers and the British Medical Association (BMA), which represents the interests of GPs.
The data also contain some financial flows which do not reach GP practices, but contribute towards overall Primary Medical Care investment. These include Information Management and Technology (IM&T), some centrally-led or procured elements and funding invested in GP practice systems and Out of Hours services. 2017/18 figures for England also include £105.65 million that was invested by Trusts in General Practice Services in Accident and Emergency (A&E) departments.
The report covers payments made to General Practices operating under GMS, PMS, APMS or Other (Non-GMS or PCTMS) contract types. Tables detailing this investment are in the accompanying Excel file.
- In 2017/18 there was an increase in the total investment in GP practices of 6.72 per cent in England, 6.37 per cent in Wales, 3.09 per cent in Northern Ireland and in Scotland 4.93 per cent.
- In real terms this equates to an increase of 4.93 per cent in England, 4.59 per cent in Wales, 1.36 per cent in Northern Ireland and in Scotland 3.17 per cent.
- At a UK level, there was an increase of 6.49 per cent in cash terms which is 4.70 per cent in real terms.
Last edited: 9 April 2019 3:07 pm